计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
西尼地平, 电压门 L 型钙通道阻滞剂
有货
为什么选择此级别
Moligand™ 级 ，适用于对基线干扰要求严格的色谱和分析工作流程。
储存与运输
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
质量文档
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
文献证明
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
概述
Cilnidipine是一种钙离子通道抑制剂。It is a dual blocker of L-type voltage-gated calcium channels in vascular smooth muscle and N-type calcium channels in sympathetic nerve terminals that supply blood vessels.An L-/N-type calcium channel protein inhibitor and blocker
Information
Cilnidipine (FRC-8653) Cilnidipine (FRC-8653) is a unique L-type and N-type calcium channel blocker, used for high blood pressure treatment.
In vitro
Cilnidipine (10 mM) suppresses the elevation of the ratio induced by 40 mM KCl, and this suppression is effectively inhibited after the treatment with omega-conotoxin GVIA.
In vivo
Cilnidipine reduces Ca(2+) influx via N-type Ca(2+) channels after NMDA receptors activation and then protects neurons against ischemia-reperfusion injury in the rat retina in vivo. Cilnidipine\xa0significantly prevents the increase in desmin staining and restores the glomerular podocin and nephrin expression compared with amlodipine in spontaneously hypertensive rat/ND mcr-cp (SHR/ND).\xa0Cilnidipine also prevents the increase in renal angiotensin II content, the expression and membrane translocation of NADPH oxidase subunits and dihydroethidium staining in SHR/ND. Cilnidipine (30 mg/kg/d as food admix) treatment suppresses the increase in systolic blood pressure in\xa0Dahl\xa0salt-sensitive rats.\xa0Cilnidipine inhibits the increase in blood urea nitrogen and decrease in creatinine clearance as well as progression of glomerular sclerosis. Cilnidipine\xa0reduces plasma norepinephrine level and plasma rennin activity compared with vehicle-treated\xa0Dahl S rats.\xa0 Cilnidipine suppresses the pressor response induced by sympathetic nerve stimulation and angiotensin II in pithed rats. Cilnidipine or omega-conotoxin MVIIA decreases mean blood pressure, but slightly increases heart rate in anesthetized rats. Cilnidipine can affect sympathetic N-type Ca(2+) channels in addition to vascular L-type Ca(2+) channels in antihypertensive doses in the rat in vivo.\xa0
Cell Data
cell lines：
Concentrations：
Incubation Time：
Powder Purity:≥99%
规格
英文别名
3-cinnamyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
规格或纯度
Moligand™, 10mM in DMSO
英文名称
Cilnidipine (FRC-8653)
生化机理
西尼地平（FRC-8653）是一种独特的 L 型和 N 型钙通道阻滞剂，用于治疗高血压。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
封闭剂
作用机制
电压门 L 型钙通道阻滞剂
名称和识别符
EC号
634-350-6
分子类型
小分子
Isomeric SMILES
CC1=C(C(C(=C(N1)C)C(=O)OC/C=C/C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC
分子量
492.52
Reaxy-Rn
36145545
Reaxys-RN link address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=36145545&ln=
技术文档
高级数据
关联靶点（人）
CACNA1C
Tclin
电压依赖性 L 型钙通道亚基 α-1C(Voltage-dependent L-type calcium channel subunit alpha-1C)
(1 活性数据)
CACNA1B
Tclin
电压依赖性N型钙通道亚基α-1B(Voltage-dependent N-type calcium channel subunit alpha-1B)
(2 活性数据)
化学和物理性质
熔点
110 °C
安全和危险性（GHS）
象形图
信号词
Danger
危险声明
H318: 造成严重的眼睛损伤
预防措施声明
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。
P305+P354+P338: 如果进入眼睛：立即用水冲洗几分钟。取下隐形眼镜（如果有的话），并且操作简单。继续冲洗。
P317: 寻求紧急医疗救助。
WGK Germany
3
RTECS
US7975550
Merck Index
2275
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
质检证书（CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
技术文档和文章
溶液计算器
产品仅提供给经过验证的企业、机构和合格的专业人员用于研发。不适用于人类、动物、诊断或治疗。
Copyright © 2023至今 上海阿拉丁生化科技股份有限公司 保留所有权利。
危险品化学品经营许可证（带存储）